Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

The Treatment of Burkitt Lymphoma with the Berlin-Frankfurt-Münster Protocol with Rituximab and Autologous Transplantation

Alessandro Broccoli, Gianmarco Bagnato, Lisa Argnani, Beatrice Casadei, Martina Cantelli, Cinzia Pellegrini, Sabrina Zoli, Emanuele Sutto, Paolo Elia Coppola, Marianna Gentilini, Alice Morigi, Matteo Carella, Gabriele Gugliotta, Laura Nanni, Vittorio Stefoni, Pier Luigi Zinzani

Blood (2023) 142 (Supplement 1): 6290.

https://doi.org/10.1182/blood-2023-178586

Published: 2023

Journal Articles

Role of Pegylated Liposomal Doxorubicin in Heavily Pretreated Relapsed Refractory Hodgkin Lymphoma Eligible for Autologous or Allogeneic Transplantation

Beatrice Casadei, Cinzia Pellegrini, Emanuele Sutto, Martina Cantelli, Lisa Argnani, Sabrina Zoli, Paolo Elia Coppola, Marianna Gentilini, Alice Morigi, Matteo Carella, Gabriele Gugliotta, Gianmarco Bagnato, Laura Nanni, Alessandro Broccoli, Vittorio Stefoni, Pier Luigi Zinzani

Blood (2023) 142 (Supplement 1): 6204.

https://doi.org/10.1182/blood-2023-178601

Published: 2023

Journal Articles

The Clinical Complexity of Langherans Cell Histiocytosis in Adult Patients: Experience of the Institute of Hematology of Bologna

Alessandro Broccoli, Gianmarco Bagnato, Lisa Argnani, Martina Cantelli, Beatrice Casadei, Cinzia Pellegrini, Sabrina Zoli, Emanuele Sutto, Paolo Elia Coppola, Marianna Gentilini, Alice Morigi, Matteo Carella, Gabriele Gugliotta, Laura Nanni, Vittorio Stefoni, Pier Luigi Zinzani

Blood (2023) 142 (Supplement 1): 6412.

https://doi.org/10.1182/blood-2023-178573

Published: 2023

Journal Articles

Rituximab As an Effective Salvage Therapy in Pretreated Hairy Cell Leukemia Patients: The Bologna Experience

Alessandro Broccoli, Lisa Argnani, Laura Nanni, Gianmarco Bagnato, Matteo Carella, Beatrice Casadei, Paolo Elia Coppola, Gabriele Gugliotta, Ginevra Lolli, Marianna Gentilini, Alice Morigi, Cinzia Pellegrini, Vittorio Stefoni, Pier Luigi Zinzani

Blood (2022) 140 (Supplement 1): 6526–6527.

https://doi.org/10.1182/blood-2022-158158

Published: 2022

Journal Articles

Brentuximab Vedotin As Single Agent in the Treatment of Relapsed/Refractory CD30 Positive Peripheral T-Cell Lymphoma Patients: A Phase 2 Study of the Fondazione Italiana Linfomi

Vittorio Stefoni, MD PhD, Paolo Corradini, Lorella Orsucci, MD, Stefano Volpetti, Lisa Argnani, Anna Dodero, Cinzia Pellegrini, Pier Luigi Zinzani, MD

Blood (2020) 136 (Supplement 1): 21.

https://doi.org/10.1182/blood-2020-136917

Published: 2020

Journal Articles

The Treatment of Hairy Cell Leukemia with a Focus on Long Lasting Responders to Cladribine: A Thirty-Year Experience from the Institute of Hematology of Bologna

Alessandro Broccoli, Carolina Terragna, Vittorio Stefoni, Cinzia Pellegrini, Beatrice Casadei, MD, Miriam Marangon, Alice Morigi, Laura Nanni, MD, Ginevra Lolli, Matteo Carella, Lisa Argnani, Michele Cavo, Pier Luigi Zinzani, MD PhD

Blood (2019) 134 (Supplement_1): 4005.

https://doi.org/10.1182/blood-2019-122832

Published: 2019

Journal Articles

Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial

Pier Luigi Zinzani, Cinzia Pellegrini, Annalisa Chiappella, Alice Di Rocco, Flavia Salvi, Maria Giuseppina Cabras, Lisa Argnani, Vittorio Stefoni

Blood (2017) 129 (16): 2328–2330.

https://doi.org/10.1182/blood-2017-01-764258

Published: 2017

Journal Articles

Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Anaplastic Large Cell Lymphoma

Blood (2016) 128 (22): 3007.

https://doi.org/10.1182/blood.V128.22.3007.3007

Published: 2016

Journal Articles

Long-Term Responders after Brentuximab Vedotin: Experience on 57 Patients with Relapsed and Refractory Hodgkin and Anaplastic Large Cell Lymphoma

Pier Luigi Zinzani, MD PhD, Letizia Gandolfi, Beatrice Casadei, Cinzia Pellegrini, Alessandro Broccoli, MD, Enrico Derenzini, MD, Federica Quirini, Lorenzo Tonialini, Michele Cavo, MD, Lisa Argnani, Vittorio Stefoni

Blood (2015) 126 (23): 2725.

https://doi.org/10.1182/blood.V126.23.2725.2725

Published: 2015

Journal Articles

18F-Fluorothymidine Positron Emission Tomography in Patients with Suspect Lymphoma Relapse

Alessandro Broccoli, MD, Lucia Zanoni, Cristina Nanni, Giancarlo Montini, Vittorio Stefoni, Cinzia Pellegrini, Letizia Gandolfi, Cristina Fonti, Filippo Lodi, Michele Cavo, MD, Stefano Fanti, Pier Luigi Zinzani, MD PhD

Blood (2015) 126 (23): 5009.

https://doi.org/10.1182/blood.V126.23.5009.5009

Published: 2015

Journal Articles

Phase II Study of the Fondazione Italiana Linfomi on Gemcitabine Plus Romidepsin (GEMRO Regimen) in Relapsed and Refractory Peripheral T-Cell Lymphoma Patients

Blood (2015) 126 (23): 3937.

https://doi.org/10.1182/blood.V126.23.3937.3937

Published: 2015

Journal Articles

Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice, the Lenamant Study

Blood (2015) 126 (23): 3946.

https://doi.org/10.1182/blood.V126.23.3946.3946

Published: 2015

Journal Articles

The Treatment of Primary Mediastinal Large B-Cell Lymphoma: A Two Decades Monocentric Experience on 98 Patients

Beatrice Casadei, MD, Alessandro Broccoli, MD, Vittorio Stefoni, MD, Cinzia Pellegrini, Letizia Gandolfi, MD, Enrico Derenzini, MD, Federica Quirini, MD, Lisa Argnani, PhD, Pier Luigi Zinzani, MD, PhD

Blood (2014) 124 (21): 4440.

https://doi.org/10.1182/blood.V124.21.4440.4440

Published: 2014

Journal Articles

Brentuximab Vedotin Followed By ABVD in Patients with Previously Untreated Hodgkin Lymphoma. a Pilot Phase II Study

Pier Luigi Zinzani, MD, PhD, Stefano Luminari, MD, Francesco Merli, Emanuela Anna Pesce, Stephane Chauvie, Cinzia Pellegrini, Luigi Marcheselli, Isabella Capodanno, MD, Fiorella Ilariucci, Massimiliano Salati, Lisa Argnani, PhD, Massimo Federico

Blood (2014) 124 (21): 3088.

https://doi.org/10.1182/blood.V124.21.3088.3088

Published: 2014

Journal Articles

Efficacy and Safety of Biosimilar Epoetin Alpha in Patients with Chronic Lymphoproliferative Syndromes and Chemotherapy-Induced Anemia: An Observational, Retrospective, Monocentric Analysis

Alessandro Broccoli, MD, Beatrice Casadei, MD, Enrico Derenzini, MD, Letizia Gandolfi, MD, Cinzia Pellegrini, Federica Quirini, MD, Vittorio Stefoni, MD, Lisa Argnani, PhD, Pier Luigi Zinzani, MD, PhD

Blood (2014) 124 (21): 5478.

https://doi.org/10.1182/blood.V124.21.5478.5478

Published: 2014

Journal Articles

Langerhans Cell Histiocytosis: A Single Institution Retrospective Analysis of Eleven Patients

Vittorio Stefoni, MD, Alessandro Broccoli, MD, Beatrice Casadei, MD, Enrico Derenzini, MD, Letizia Gandolfi, MD, Cinzia Pellegrini, Federica Quirini, MD, Lisa Argnani, PhD, Pier Luigi Zinzani, MD, PhD

Blood (2014) 124 (21): 5458.

https://doi.org/10.1182/blood.V124.21.5458.5458

Published: 2014

Journal Articles

Sequential R-CHOP and R-FM Chemotherapy Followed By Autologous Stem Cell Transplantation Results In High Rates Of Long Term Remission In Advanced Follicular Lymphoma

Enrico Derenzini, MD, Vittorio Stefoni, MD, Beatrice Casadei, MD, Cinzia Pellegrini, MD, Alessandro Broccoli, MD, Stefano Fanti, MD, Letizia Gandolfi, MD, Giulia Stefani, MD, Lisa Argnani, PhD, Pier Luigi Zinzani, MD

Blood (2013) 122 (21): 5543.

https://doi.org/10.1182/blood.V122.21.5543.5543

Published: 2013

Journal Articles

Primary Mediastinal Large B-Cell Lymphoma: Investigation On The Role Of Rituximab and PET During Treatment

Pier Luigi Zinzani, Cinzia Pellegrini, MD, Beatrice Casadei, MD, Enrico Derenzini, MD, Alessandro Broccoli, MD, Letizia Gandolfi, MD, Federica Quirini, MD, Lisa Argnani, PhD, Vittorio Stefoni, MD

Blood (2013) 122 (21): 3046.

https://doi.org/10.1182/blood.V122.21.3046.3046

Published: 2013

Journal Articles

Fludarabine, Mitoxantrone and Rituximab (FMR) Regimen in Previously Untreated Patients with Indolent Non-Hodgkin Lymphoma: Efficacy, Safety and PET Data On 285 Patients.

Pier Luigi Zinzani, MD, Cinzia Pellegrini, MD, Enrico Derenzini, MD, Alessandro Broccoli, MD, Letizia Gandolfi, MD, Vittorio Stefoni, MD, Beatrice Casadei, MD, Federica Quirini, MD, Lisa Argnani, PhD

Blood (2012) 120 (21): 2736.

https://doi.org/10.1182/blood.V120.21.2736.2736

Published: 2012

Journal Articles

The Role of Interim-PET and Final-PET in the Outcome of Peripheral T-Cell Lymphoma (PTCL) Treated At the Diagnosis with CHOP.

Cinzia Pellegrini, MD, Beatrice Casadei, MD, Enrico Derenzini, MD, Alessandro Broccoli, MD, Vittorio Stefoni, MD, Letizia Gandolfi, MD, Federica Quirini, MD, Lisa Argnani, PhD, Pier Luigi Zinzani, MD

Blood (2012) 120 (21): 2721.

https://doi.org/10.1182/blood.V120.21.2721.2721

Published: 2012

NARROW

The Treatment of Burkitt Lymphoma with the Berlin-Frankfurt-Münster Protocol with Rituximab and Autologous Transplantation

Role of Pegylated Liposomal Doxorubicin in Heavily Pretreated Relapsed Refractory Hodgkin Lymphoma Eligible for Autologous or Allogeneic Transplantation

The Clinical Complexity of Langherans Cell Histiocytosis in Adult Patients: Experience of the Institute of Hematology of Bologna

Rituximab As an Effective Salvage Therapy in Pretreated Hairy Cell Leukemia Patients: The Bologna Experience

Brentuximab Vedotin As Single Agent in the Treatment of Relapsed/Refractory CD30 Positive Peripheral T-Cell Lymphoma Patients: A Phase 2 Study of the Fondazione Italiana Linfomi

The Treatment of Hairy Cell Leukemia with a Focus on Long Lasting Responders to Cladribine: A Thirty-Year Experience from the Institute of Hematology of Bologna

Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial

Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Anaplastic Large Cell Lymphoma

Long-Term Responders after Brentuximab Vedotin: Experience on 57 Patients with Relapsed and Refractory Hodgkin and Anaplastic Large Cell Lymphoma

18F-Fluorothymidine Positron Emission Tomography in Patients with Suspect Lymphoma Relapse

Phase II Study of the Fondazione Italiana Linfomi on Gemcitabine Plus Romidepsin (GEMRO Regimen) in Relapsed and Refractory Peripheral T-Cell Lymphoma Patients

Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice, the Lenamant Study

The Treatment of Primary Mediastinal Large B-Cell Lymphoma: A Two Decades Monocentric Experience on 98 Patients

Brentuximab Vedotin Followed By ABVD in Patients with Previously Untreated Hodgkin Lymphoma. a Pilot Phase II Study

Efficacy and Safety of Biosimilar Epoetin Alpha in Patients with Chronic Lymphoproliferative Syndromes and Chemotherapy-Induced Anemia: An Observational, Retrospective, Monocentric Analysis

Langerhans Cell Histiocytosis: A Single Institution Retrospective Analysis of Eleven Patients

Sequential R-CHOP and R-FM Chemotherapy Followed By Autologous Stem Cell Transplantation Results In High Rates Of Long Term Remission In Advanced Follicular Lymphoma

Primary Mediastinal Large B-Cell Lymphoma: Investigation On The Role Of Rituximab and PET During Treatment

Fludarabine, Mitoxantrone and Rituximab (FMR) Regimen in Previously Untreated Patients with Indolent Non-Hodgkin Lymphoma: Efficacy, Safety and PET Data On 285 Patients.

The Role of Interim-PET and Final-PET in the Outcome of Peripheral T-Cell Lymphoma (PTCL) Treated At the Diagnosis with CHOP.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only